FDA Licenses ORTHO™ Sera designed for Extended Phenotype Testing for Use with Ortho ID-MTS™ Gel Card Technology

FDA Licenses ORTHO™ Sera designed for Extended Phenotype Testing for Use with Ortho ID-MTS™ Gel Card Technology

Sep 26, 2017

FDA Licenses Blood Grouping Reagents for Extended Phenotype Testing: ORTHO™ Sera Featured in CLP

September 26, 2017
“Ortho Sera helps increase confidence in the lab and allow staff to focus on improving lab efficiency,” says Robert Yates, chief operating officer at Ortho Clinical Diagnostics. “This addition our comprehensive, integrated product portfolio furthers our goal of helping lab technologists deliver reliable results to their patients, despite pressures caused by limited resources and staff constraints.”

Read the article.
 
 
${loading}